[1] LI LiminBI Yaqiong GUO Wenxin YUN Xiaohua XIA Yuan LI Minhui ZHANG Chunhong,.Evaluation of the Development Status of Mongolian Medicin Quality Standards Based on Big Data Analysis [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2023, (05): 119-126. [doi: 10.13424/j.cnki.jsctcm.2023.05.020]
Evaluation of the Development Status of Mongolian Medicin Quality Standards Based on Big Data Analysis
- Article number:
- 2096-1340(2023)05-0119-08
- Keywords:
- Key words： Big data; Bashaga; Mongolian medicinal herbs; Quality evaluation; Development status
- ZTFLH:
- R926
- Code:
- A
- Abstract:
- Abstract： Mongolian medicine is a medical system with Mongolian ethnic characteristics gradually formed by the Mongolian people through longterm disease prevention and treatment,as well as drug use.As the source and cornerstone of Mongolian medicinal materials,their quality is closely related to the survival and continuity of the entire Mongolian pharmaceutical system and the healthy development of the entire Mongolian pharmaceutical industry.There are problems in the quality evaluation of Mongolian medicinal materials,such as confusion in the basic sources and simple and outdated evaluation methods.Taking the “Research on the Sorting and Quality Evaluation of Bashaga Mongolian Medicinal Varieties” project of the National Natural Science Foundation of China as an example,based on big data,a primary database of target medicinal materials is established for Mongolian medicinal materials,and the basic research on the pharmacodynamics of key research varieties is selected,And conduct research on the evaluation indicators included in modern quality standards and the clinical pharmacodynamics of key varieties of Mongolian medicine,preliminarily explore and analyze the comprehensive quality evaluation methods,aiming to provide some reference for the healthy development of Mongolian medicine.
References:
［1］张春红,赵志英,哈斯巴特尔,等.蒙药:从传统实践到科学发展［J］.中国中药杂志,2015,40(13):2492-2495.
［2］杨薇,崔英子,杨海淼,等.医疗大数据在中医药研究领域的应用与思考［J］.长春中医药大学学报,2016,32(3):625-627.
［3］吴俊玲.大数据时代中医药期刊面临的机遇和挑战［J］.中国中医药图书情报杂志,2015,39(3):60-62.
［4］吴其国,胡叶青,查元,等.大数据在中医药领域中的应用现状［J］.广西中医药大学学报,2016,19(1):153-156.
［5］濮文渊,凌云,周春祥.基于大数据与中医药研究现状对慢病防治的启示［J］.中医杂志,2016,57(20):1795-1797.
［6］晓花,朱翔慧,伊乐泰,等.“地格达”类蒙药在蒙药复方制剂中的应用情况［J］.中国现代中药,2018,20(12):1583-1592.
［7］周保昌，刘一波，高原，等.基于生药学与药用植物亲缘学的“巴沙嘎”类蒙古族药品种整理［J］.中国现代中药，2002，24（9）：1693-1700.
［8］布日额.蒙医用达克沙的品种整理与质量研究［J］.中国民族医药杂志,2002,8(2):37-40.
［9］柳白乙拉.蒙药正典［M］.北京:民族出版社,2006.
［10］内蒙古自治区卫生厅.内蒙古蒙药材标准蒙汉对照［M］.赤峰:内蒙古科学技术出版社出版,1987.
［11］中华人民共和国卫生部药典委员会.中华人民共和国卫生部药品标准·蒙药分册［S］.1998.
［12］内蒙古自治区食品药品监督管理局.内蒙古蒙药材标准:2015年版［M］.增补本.呼和浩特:内蒙古人民出版社,2018.
［13］国家中医药管理局《中华本草》编委会.中华本草:蒙药卷［M］.上海:上海科学技术出版社,2004.
［14］罗布桑.蒙药学 蒙文［M］.呼和浩特:内蒙古人民出版社,2006.
［15］王布和朝鲁.《认药白晶鉴》植物药品种整理研究［D］.通辽:内蒙古民族大学,2012.
［16］国家药典委员会.中华人民共和国药典:一部［M］.北京:中国医药科技出版社,2020.
［17］黄璐琦,王永炎.全国中药资源普查技术规范［M］.上海:上海科学技术出版社,2015.
［18］Xie XR,Zhang L,Li X,et al.Liangxue Jiedu formula improves psoriasis and dyslipidemia comorbidity via PI3K/Akt/mTOR pathway［J］.Frontiers in Pharmacology,2021,12:591608.
［19］董永喜,刘星星,董莉,等.白及多糖对血热出血模型大鼠的止血作用及机制研究［J］.中国药房,2016,27(31):4347-4350.
［20］朱耿隆,蔡潮农,肖笑雨,等.梗阻性黄疸SD大鼠肝热缺血再灌注损伤模型的建立［J］.中华普通外科学文献(电子版),2016,10(3):163-167.
［21］马丹娟.登革病毒感染湿热证小鼠模型建立及清热祛湿法作用机理探讨研究［D］.广州:南方医科大学,2011.
［22］陈兰英，罗园红.芍药苷和甘草次酸配伍对抑制LPS诱导的RAW264.7细胞炎症协同作用研究［C］.中华中医药学会中药实验药理分会学术年会，2014.
［23］杨扬,陈方圆,柳振华,等.基于IL-6/STAT3信号通路研究清热排毒胶囊对急性痛风性关节炎模型大鼠淋巴细胞增殖的影响［J］.世界最新医学信息文摘,2018,18(55):1-3.
［24］Wu P,Liang Q,Feng P,et al.A novel brucine gel transdermal delivery system designed for antiinflammatory and analgesic activities［J］.International Journal of Molecular Sciences,2017,18(4):E757.
［25］Wang G,Hu Z,Song X,et al.Analgesic and antiinflammatory activities of resveratrol through classic models in mice and rats［J］.EvidenceBased Complementary and Alternative Medicine,2017,2017:5197567.
［26］Li QN,Huang ZP,Gu QL,et al.Synthesis and biological evaluation of novel tanshinone IIA derivatives for treating pain［J］.Chinese Journal of Natural Medicines,2018,16(2):113-124.
［27］Li Y,Liu Y,Yang Q,et al.Antiinflammatory effect of feiyangchangweiyan capsule on rat pelvic inflammatory disease through JNK/NF-κB pathway［J］.EvidenceBased Complementaryand Alternative Medicine:ECAM,2018,2018:8476147.
［28］刘旸.活血化瘀和清热解毒方药对急性痛风性膝关节炎家兔模型的肿瘤坏死因子α(TNF-α)影响的实验研究［D］.沈阳:辽宁中医学院,2002.
［29］李孜怡.金雀凉血解毒颗粒对大鼠湿疹模型免疫调节作用机制研究［D］.哈尔滨:黑龙江中医药大学,2018.
［30］Chen GR,Zhang G,Li MY,et al.The effective components of Huanglian Jiedu Decoction against Sepsis evaluated by a lipid Abased affinity biosensor［J］.Journal of Ethnopharmacology,2016,186:369-376.
［31］李妍,钱丽燕,唐朋林,等.热毒血瘀证结肠癌荷瘤小鼠模型的建立及清热解毒活血化瘀法对其的影响［J］.中华中医药杂志,2017,32(3):1336-1339.
［32］王珏云,赵公泽,白鑫洁,等.柴胡解毒汤对实验性酒精性肝纤维化复合模型大鼠ColⅣ,HA的影响［J］.现代生物医学进展,2017,17(11):2016-2019.
［33］张润田，陈曦，霍春波，等.消银解毒颗粒对Jurkat细胞异常增殖模型的影响［J］.中医杂志，2017，58（12）：1149-1052.
［34］张亚平,陶振刚,宋振举,等.疏风解毒胶囊对小鼠病毒性心肌炎模型的影响［J］.中草药,2016,47(1):110-113.
［35］刘杨.清热解毒方对大鼠下肢丹毒的药效作用和机理研究［D］.苏州:苏州大学,2015.
［36］Karamese M,Erol HS,Albayrak M,et al.Antioxidant and antiinflammatory effects of apigenin in a rat model of Sepsis:an immunological,biochemical,and histopathological study［J］.Immunopharmacology and Immunotoxicology,2016,38(3):228-237.
［37］周腊梅,汪悦.凉血化瘀解毒法对MRL/lpr系统性红斑狼疮模型鼠肝肾功能的相关性研究［J］.中医学报,2011,26(2):179-182.
［38］杨菊,方泰惠,王志英.化肝解毒汤对慢性乙肝模型大鼠一氧化氮及一氧化氮合酶的影响［J］.中医学报,2010,25(3):478-480.
［39］Dehn PF,White CM,Conners DE,et al.Characterization of the human hepatocellular carcinoma (hepg2) cell line as an in vitro model for cadmium toxicity studies［J］.In Vitro Cellular & Developmental Biology Animal,2004,40(5/6):172-182.
［40］Wang CC,Zang EH,Zhang CH,et al.Chemical constituents of Odontites serotina (Lam.) Dumort.(Orobanchaceae)［J］.Biochemical Systematics and Ecology,2020,90:104039.
［41］潘国庆,马立闪.HPLC同时测定塞北紫堇中的2种生物碱［J］.华西药学杂志,2016,31(6):636-637.
［42］李怀平.藏药塞北紫堇总生物碱有效部位研究［D］.济南:山东大学,2014.
［43］高坤,李旭琴,刘安,等.西北高寒植物长果婆婆纳的化学成分［J］.西北植物学报,2003,23(4):633636.
［44］向彦妮.羊踯躅根的生药学研究［D］.武汉：华中科技大学，2004.
［45］张小红,董磊迟,李会军,等.高效液相色谱蒸发光散射检测法测定闹羊花中闹羊花毒素Ⅱ的含量［J］.中国新药杂志,2013,22(5):602-604,608.
［46］张枝润,周成,娄志华,等.HPLCELSD法测定闹羊花中RhodojaponinⅢ和RhodojaponinⅥ含量［J］.天然产物研究与开发,2013,25(9):1234-1236,1204.
［47］江莎,张玲,张小琼.中药羊踯躅的应用及中毒急救研究进展［J］.中国中医急症,2022,31(5):937-940.
［48］张午寅,王广义.羊踯躅研究进展［J］.广东化工,2021,48(11):80-81.
［49］赵三强.浅谈大数据在中医药领域的应用［C］.中国生物医学工程学会中医药工程分会学术年会暨数字中医药协同创新高层论坛，2013.
［50］梁杨,丁长松,黄辛迪,等.大数据环境下的中医药数据管理策略［J］.中国中药杂志,2018,43(4):840-846.
［51］李振皓,钱忠直,程翼宇.基于大数据科技的中药质量控制技术创新战略［J］.中国中药杂志,2015,40(17):3374-3378.
［52］吕庆莉.数据挖掘与复杂网络的融合及其在中医药领域应用［J］.中草药,2016,47(8):1430-1436.
［53］孙继佳,蒋健,严广乐,等.复杂网络理论及其在中医学研究中的应用［J］.复杂系统与复杂性科学,2008,5(2):55-61.
Memo
基金项目：国家自然科学基金资助项目(81874336)；国家自然科学基金资助项目(82160810)；内蒙古自治区教育科学规划课题(NGJGH2021181)；自治区中医药（蒙医药）中青年领军人才培育项目(2022-［RC001］)；内蒙古自治区科技计划项目(2020GG0144)；内蒙古科技计划项目(2020SGG0128)；内蒙古自治区卫生健康委医疗卫生科技计划项目(202202142)；内蒙古医科大学重点项目(YKD2021ZD005)；内蒙古医科大学优秀教学团队(NYJXTD202103)；内蒙古